[The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
Ebert
M P
MP
II. Medizinische Klinik des Klinikums rechts der Isar Technische Universität München, München. Matthias.Ebert@lrz.tum.de
Schmid
R M
RM
D000230:Adenocarcinoma / Q000628:therapy; D001661:Biliary Tract Neoplasms / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D004067:Digestive System Neoplasms / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000628:therapy; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy; D020360:Neoadjuvant Therapy / Q000379:methods* / Q000639:trends; D010190:Pancreatic Neoplasms / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy